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1. Introduction 3. Results 
Xanthines are well-known inhibitors of cyclic 
nucleotide phosphodiesterases andamong them, 
1-methyl-3-isobutylxanthine (MIX) is the most potent 
[ 1 ]. In detailed kinetic studies, MIX has been shown 
to inhibit competitively the calmodulin-activated 
phosphodiesterase from porcine coronary arteries [2]. 
MIX is now very commonly used in intact cells to 
inhibit the degradation of cyclic nucleotides and raise 
their concentrations [3]. Here, we demonstrate a dis- 
tinct, direct mechanism of activation by MIX of an 
isolated positively cooperative form of the soluble rat 
liver phosphodiesterases, the cGMP-stimulated nzyme 
[4,5]. The latter mechanism is quite different from 
the one characterizing cGMP activation [6]. 
2. Materials and methods 
The rat liver cGMP-stimulated phosphodiesterase 
was prepared as in [6], except hat all preparative 
buffers contained the following protease inhibitors: 
phenylmethylsulfonyl fluoride, 75 mg/l (solubilized 
first in 1.5 ml dimethylsulfoxide), benzamidine, 
0.1 mM, leupeptin, 5/IM. Phosphodiesterase ctivity 
was assayed as in [6]. 5'-Nucleotidase (Crotalus atrox 
venom), phenylmethylsulfonyl fluoride, benzamidine 
and 1-methyl-34sobutylxanthine wer from Sigma 
(St Louis MO). Leupeptin was supplied by Peptide 
Institute (Osaka). 6-Chloropurineriboside 3',5'-mono- 
phosphate was a generous gift of Dr Jastorff (Univer- 
sity of Bremen). 
Abbreviations: MIX, 1-methyl-3-isobutylxanthine; cAMP,
adenosine 3',5'-monophosphate; cGMP, guanosine 3',5'-mono- 
phosphate 
Analysis of the cGMP-stimulated phosphodiesterase 
reveals a positively cooperative kinetic behavior with 
respect to cAMP as substrate. At 3/.tM cGMP shifts 
the cooperative kinetic behavior of the enzyme to a 
normal Michaelis-Menten system and increases the 
affinity of the phosphodiesterase for cAMP [4,5,7]. 
At low concentrations (3-50/JM), MIX stimulated 
basal cAMP phosphodiesterase ctivity (fig. 1). This 
particular effect of the xanthine was only detected in 
the absence of cGMP and at low cAMP substrate l vels 
(3-5/JM). The maximal stimulation (200-300% of 
control activity depending on the preparation) was 
obtained at ~50/~M MIX (fig.l). At higher [cAMP] 
(100/.Ai), 50/JaM MIX decreased cAMP hydrolysis 
(table i). When cGMP was added to the incubation 
medium, the stimulatory effect of MIX was markedly 
reduced: in the presence of 0.2/.tM cGMP, the stimu- 
latory effect of MIX was barely detectable, and the 
inhibitory effect of 0.1 or 0.3 mM MIX was strength- 
ened (table 2). Consequently, the factor of cGMP 
stimulation was progressively reduced as the concen- 
tration of the xanthine increased: at 0.3 mM MIX, 
the cGMP-activating effect (at 0.2 ~M) was no longer 
observed (table 2). In the presence of 3 pM cGMP, 
the cAMP phosphodiesterase ctivity exhibited a linear 
double-reciprocal plot and MIX (over 0.01-0.2 mM) 
showed linear competitive inhibition with respect to 
cAMP (K i = 18 ~tM, fig.2). A similar mechanism of 
inhibition and equipotent Ki-values were obtained 
with cGMP as substrate over 5-100 ~tM (not shown). 
The two effects of MIX (stimulation and inhibi- 
tion) were reproduced with 50 ~uM 6-chloropurine- 
riboside 3',5'-monophosphate, n analogue of the 
substrate and potent inhibitor [6], but not with 
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Fig. 1. Dose-response curve between the stimulation of 
cAMP phosphodiesterase ctivity and the concentration of
1-methyl-3-isobutylxanthine (MIX). cAMP was 3 ~M. Results 
are expressed as % of the control ± SD. 
0.2/aM cGMP for which only the stimulatory effect 
was observed (table 1). Complete substrate-veloci ty 
relationships indicated that MIX, 6-chloropurine- 
riboside 3',5'omonophosphate nd cGMP all attenuated 
Table 2 
Effect of MIX on the activity of the cGMP-stimulated 
phosphodiesterase 
Addition Phosphodiesterase ct. 
(pmol. min -t . mg protein -1 ) 
Control cGMP (0.2 tzM) 
None 149.7 -+ 6.2 754.0 ± 7.7 (5.0) 
MIX 
0.01 mM 231.3 ± 5.0 872.1 -+ 21.1 (3.8) 
0.03 mM 301.6 -+ 12.1 695.9 ± 13.8 (2.3) 
0.1 mM 250.4 _+ 11.2 327.3 ± 12.4 (1.3) 
0.3 mM 110.7 ± 9.5 118.5 +- 1.8 (1.1) 
cAMP phosphodiesterase ctivity was assayed at 3 uM cAMP 
as substrate, in the absence and presence of 0.2 vM cGMP 
(effector). Results are means of triplicates -+ SD. The factor 
of activation by cGMP is given in parenthesis 
the positively cooperative character of  the enzyme. 
However, in contrast o cGMP, the xanthine or the 
cAMP analogue did not decrease the app. Kin-value 
for cAMP. 
4. Discussion 
The stimulatory effect of  MIX on cAMP hydrolysis 
by the cGMP-stimulated phosphodiesterase could 
appear as a paradox, since xanthines are well-known 
as inhibitors of  phosphodiesterases of  mammalian 
origin [ 1 ]. Actually, this observation isnot unexpected: 
theoretical enzymology shows that a competit ive 
inhibitor can increase the velocity of  a positively 
cooperative nzyme provided the competitor  mimics 
the cooperative substrate binding and that low con- 
Table 1 
Effect of MIX, 6-chloropurineriboside 3',5'-monophosphate ndcGMP on cAMP 
phosphodiesterase ctivity (pmol cAMP hydrolyzed, min -t . mg protein -t) 
Substrate Control MIX 6-Chloropurine- cGMP 
cAMP (tzM) (50 uM) riboside 3',5'- (0.2 vM) 
monophosphate 
(50 t~M) 
5 152± 39 314-+ 7 609-+ 13 696± 29 
10 531± 5 772± 15 1192± 8 1621± 95 
25 2784 ± 23 2072 -+ 65 2649 ± 9 4337 ± 39 
50 5829 ± 98 3658 ± 81 4336 ± 109 6886 ± 260 
100 7650±73 5401-+53 6069± 49 7983± 147 
Results are means of triplicates -+ SD 
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Fig.2. Inhibitory effect of 1-methyl-3-isobutylxanthine (MIX)
on cAMP hydrolysis (double-reciprocal plot). Activity was 
measured inthe presence of 3/~M cGMP (effector). Substrate 
ranges hown are 2-100 ~ for cAMP. Results are means of 
triplicate determinations and are representative of xperi- 
ments with 3 different preparations. 
centrations of both the substrate and the competitor 
are used [8]. This phenomenon can occur in the case 
of concerted or sequential cooperativity [8,9] and 
has already been observed for other allosteric enzymes, 
e.g., aspartate transcarbamoylase (stimulated by sub- 
strate analogues) [10]. The stimulatory effect of MIX 
has properties consistent with the theoretical predic- 
tions: it is only observed at low concentrations of
both the substrate cAMP and the xanthine and is asso- 
ciated with an attenuation of the cooperative inter- 
actions inside the enzyme. Furthermore, it is no longer 
detected when the positive cooperativity of the 
enzyme is partially or completely abolished, that is 
when cGMP is the substrate or when cGMP activates 
cAMP hydrolysis. In these last conditions MIX is a 
pure inhibitor: double-reciprocal plots demonstrate 
the competitive nature of this inhibition (fig.2). 
As shown in table 1, only MIX, but not cGMP, has 
a marked inhibitory effect at high cAMP concentra- 
tion (100/IM). Since the effect of the xanthine can be 
entirely explained by its binding to catalytic sites 
interacting with each other in a positively cooperative 
way, the effect of cGMP must follow another mech- 
anism of activation presumably involving a distinct 
regulatory site [8]. Evidence for such a regulatory site 
was recently obtained with the use of cyclic nucteotide 
derivatives [6]. 
As shown in table 2, the inhibition of the phospho- 
diesterase by MIX is much more potent in the presence 
than in the absence of cGMP. This could be interpreted 
in two ways: 
(i) cGMP bound to the regulatory site increases the 
affinity of catalytic sites for MIX; or 
(ii) MIX, in addition to being a competitive inhibitor 
of the catalytic sites, is a competitive antagonist 
blocking the binding of cGMP to its activatory 
site. 
Our kinetic data cannot distinguish between these 
two interpretations. 
In conclusion, these results are consistent with a 
competitive interaction of MIX at the catalytic sites 
of the rat liver cGMP-stimulated phosphodiesterase. 
An additional competitive interaction with the cGMP 
regulatory site cannot be excluded by our data but is 
not necessary to explain them. The mechanism of 
MIX stimulation described here is quite different 
from the long-term mechanism of activation by MIX 
of a cAMP-specific phosphodiesterase in intact human 
lymphocytes [11 ]. Since it is observed at rather low 
concentrations, it is tempting to speculate that some 
of the pharmacological properties of the xanthines 
might be related to activatory rather than inhibitory 
effects on the phosphodiesterases [12]. 
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